Strengthening its wellness portfolio through the $1.2B acquisition of Grüns and leveraging a proven M&A playbook to scale digital-first brands globally.

Aggressively acquiring high-growth supplement brands like Grunz to expand into the consumer health sector.

Its acquisition of Onnit in 2021 validates the strong potential of the nootropics market and shows a successful exit path for supplement brands, highlighting Unilever's strategic positioning.

Received a very strong, bullish endorsement for its subsidiary Onnit, with Joe Rogan calling its 'Alpha Brain' product the 'best' and 'most effective' nootropic, backed by scientific studies.

The company's ownership of Onnit gives it a foothold in the expanding wellness and nootropics category, capitalizing on growing consumer interest in cognitive enhancement products.

The spin-off of the ice cream division could be a positive for investors by unlocking value and shedding a business unit causing public relations and management challenges, allowing focus on core segments.

Investors can gain exposure to the success of strong, growing brands like Nutrafol by investing in its parent company, Unilever, which uses acquisitions of innovative brands to fuel its future growth.